NCT01333423 2012-06-26Maximum Tolerated Dose (MTD) of Liposomal Doxorubicin in Combination With Seliciclib for Patients With Metastatic Triple Negative Breast Cancer (TNBC)M.D. Anderson Cancer CenterPhase 1 Withdrawn